Share on

North America Nuclear Medicine Market Research Report - Segmented By SPECT, PET, Application & Country (the United States, Canada, & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 99
Pages: 143
Formats: report pdf report excel report power bi report ppt

North America Nuclear Medicine Market Size (2022 to 2027)

The North American nuclear medicine market is estimated to be USD 8.63 billion by 2027 and USD 5.05 billion in 2022, growing at a CAGR of 11.3% during the forecast period.

The growing population diagnosed with cancer in the North American region is one of the major factors promoting the nuclear medicine market in North America. There are 2 million new cancers reported in the United States. Cancer is a dangerous disease that leads to death in the short term. Therefore, analysis of which part of the body is affected by cancer cells is essential for the treatment procedure. For this purpose, nuclear medicine has come into account. Nuclear medicine imaging for cancer is used for diagnosis, planning, and evaluating patient response to treatment. In this process, the researcher found several chemicals absorbed by specific organs and decided which organ in the body affects the cancer cells. Increasing awareness about this procedure among people suffering from different types of cancer and taking respective treatments for cancer drives the nuclear medicine market forward.

However, one factor that restrains the growth of the nuclear medicine market in this region is the lack of essential equipment for radiation protection and research facilities in some regions. Other factors, such as the high cost of the procedures, lack of specialized personnel, and lack of awareness about the procedure, hamper the market growth during the forecast period. In addition, radiation may occur health risks to some people who are sensitive to the radiation, and for some people, it can temporarily reduce bone marrow counts. Health risks for some people due to this nuclear medicine, side effects after exposure to the radiation used for the procedure, and increasing alternative therapy also hinder the market growth in this region.

This research report on the North American nuclear medicine market has been segmented and sub-segmented into the following categories:

By Type:

  • SPECT
  • PET

By Application:

  • Cardiology
  • Lymphoma
  • Thyroid
  • Neurology
  • Oncology
  • others

By Country:

  • United States
  • Canada
  • Rest of North America

North America had the highest share of the global market in 2021. Increasing advanced technologies and the introduction of new radiopharmaceuticals for diagnosis and therapy in this region drive nuclear medicine growth in the United States. The U.S. government is taking initiatives for cost-effective procedures using nuclear medicine and providing various training programs for developing nuclear medicine for different diseases. As a result, the number of nuclear medicine procedures in the United States has recently increased. The cardiology sector has the most growth due to the nuclear medicine used in this region. The oncology sector has maximum growth due to this medicine usage. The number of positron emission tomography procedures is increasing in the United States is nearly 1.5 million per year.

KEY MARKET PLAYERS:

A few of the notable companies operating in the North America Nuclear Medicine Diagnostic Market are Cardinal Health, Inc., Bracco Imaging S.p.A, G.E. Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging and Mallinckrodt PLC.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample